StreetAlpha
13F holdings · Q3 2026

Checkpoint Capital

San Francisco, CA · files as Checkpoint Capital L.P.
Know the moment Checkpoint Capital filesYou follow Checkpoint Capital An email or push as soon as its next 13F reaches the SEC, with every stock it bought, sold and trimmed. Next 13F due by Feb 15, 2027
Holdings as of Sep 30, 2026Filed Nov 13, 2026Next filing due Feb 15, 2027CIK 1977548

Checkpoint Capital reported 8 stocks worth $442M in its 13F filing for Q3 2026, filed Nov 13, 2026. Its largest holdings are ARGX (39.4%), RYTM (26.2%) and RVMD (19.6%). Compared with Q2 2026, the fund opened new positions in SEPN and OCS and added to ARGX, RYTM and RVMD.

Latest filing: what Checkpoint Capital did in Q3 2026

vs Q2 2026
Filed 13F-HRView on SEC ↗
2 new6 added0 trimmed0 sold outBought about $71.2M · sold about $0
New 2
Added 6
See all 6 →
Trimmed 0

None

Sold out 0

None

Dollar changes use the share change at the quarter end price. New and sold out show the whole position.

Reported value$442M+13.5% vs last quarter
Stocks held82 new · 0 sold out
Top 5 weight98.8%very concentrated
Turnover16%of the portfolio changed

Portfolio at a glance

share of reported value · Q3 2026
🔒 A free account shows every holding, what the fund sold and its options.Create free account

Holdings

#StockValueWeightSharesChangeShares, 8 qtrsHeld
1
ARGX
Argenx SE
$174M39.4%182K+50K (+38%)8 of 8
2
RYTM
Rhythm Pharmaceuticals Inc
$116M26.2%1.2M+31K (+3%)8 of 8
3
RVMD
Revolution Medicines Inc
$86.8M19.6%423K+13K (+3%)8 of 8
4
CYTK
Cytokinetics Inc
$34.1M7.7%517K+42K (+9%)6 of 8
5
IRON
Disc Medicine Inc
$26.2M5.9%400K+160K (+67%)8 of 8
6
SEPN
Septerna Inc
$2.5M0.6%64KNew position5 of 8
7
TRVI
Trevi Therapeutics Inc
$2M0.4%137K+62K (+83%)4 of 8
8
OCS
Oculis Holding AG
$929K0.2%100KNew position1 of 8

Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.

Reported value

last 8 quarters
$196MQ4 '24
$182MQ1 '25
$215MQ2 '25
$298MQ3 '25
$316MQ4 '25
$279MQ1 '26
$390MQ2 '26
$442MQ3 '26

The value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.

Filings for Q3 2026

straight from the SEC
FiledFormQuarter
Nov 13, 202613F-HRQ3 2026SEC filing ↗

Other superinvestors

All hedge fund holdings →

Checkpoint Capital 13F FAQ

What does Checkpoint Capital own?

Checkpoint Capital reported 8 stocks worth $442M in its 13F filing for Q3 2026, filed Nov 13, 2026. Its largest holdings are ARGX (39.4%), RYTM (26.2%) and RVMD (19.6%). The table above lists every position in the filing (the top 10 without an account).

What did Checkpoint Capital buy and sell in Q3 2026?

Compared with Q2 2026: 2 new positions, 6 added to, 0 trimmed and 0 sold out. New positions include SEPN and OCS.

When will Checkpoint Capital file its next 13F?

Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.

How much is Checkpoint Capital's portfolio worth?

The Q3 2026 filing reports $442M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.